Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)

NCT01902966 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped low accrual and lack of funding

Conditions

Cervical Cancer

Interventions

DRUG: Propranolol
BEHAVIORAL: Diary
BEHAVIORAL: Relaxation Audio Recording
BEHAVIORAL: Questionnaires

Sponsor

M.D. Anderson Cancer Center